Myomo (MYO) Cash & Equivalents Growth (3y) (2019 - 2025)
Myomo (MYO) Cash & Equivalents Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -9.44% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 19.87% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 36.60% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 40.99% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 21.52% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -0.70% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 16.75% |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 34.11% |
| 10 | Myomo | 43.43 Mn | 24.46 Mn | - | 40.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 40.12% |
| Sep 30, 2025 | 20.44% |
| Jun 30, 2025 | 12.61% |
| Mar 31, 2025 | 15.94% |
| Dec 31, 2024 | 16.82% |
| Sep 30, 2024 | -17.82% |
| Jun 30, 2024 | -24.85% |
| Mar 31, 2024 | -32.11% |
| Dec 31, 2023 | -17.51% |
| Sep 30, 2023 | -19.64% |
| Jun 30, 2023 | -17.59% |
| Mar 31, 2023 | -12.29% |
| Dec 31, 2022 | 6.18% |
| Sep 30, 2022 | 19.57% |
| Jun 30, 2022 | 15.35% |
| Mar 31, 2022 | 11.91% |
| Dec 31, 2021 | 33.39% |
| Sep 30, 2021 | 11.50% |
| Jun 30, 2021 | 5.64% |
| Mar 31, 2021 | 7.16% |